申请人:ELI LILLY AND COMPANY
公开号:EP0587378A1
公开(公告)日:1994-03-16
The administration of a xanthine oxidase inhibitor is effective for the treatment or prevention of the excessive resorption of bone in conditions such as osteoporosis and the like.
服用
黄嘌呤氧化酶
抑制剂可有效治疗或预防骨质疏松症等情况下的骨过度吸收。